Page 71 - MNU-PM502- Pharmaeutical Microbiology Theoritical Book
P. 71
Pharm D- Clinical Pharmacy Program Third Level Pharmaceutical Microbiology& Antimicrobials (PM 502)
Monitoring pharmaceutical ingredients, and packaging components
Water
- Water systems should be monitored at points of use, storage tanks.
- Sterile products are manufactured using water for injection (WFI) as ingredient
water
- The USP-recommended specifications are
- as purified <100 CFU/mL
- Highly purified and WFI 10 CFU/100mL
Container Integrity Testing
• Integrity of container/closure system is initially validated by
• Filling container with sterile growth medium
• Then inserting container in broth containing
10 CFU/ml of suitable microorganism
Media Fills Test (Process simulation)
• the performance of an aseptic manufacturing procedure using a sterile
microbiological growth medium in place of the drug solution.
• to test whether the aseptic procedures are adequate to prevent contamination
during actual drug production.
• A media fill is one part of the validation of an aseptic manufacturing process
58